PALLET: The Pediatric ALL Evaluation and Trial

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago (Other)
Overall Status
Recruiting
CT.gov ID
NCT04825587
Collaborator
Children's Hospital of Philadelphia (Other), Texas Children's (Other), UCSF Benioff Children's Hospital - San Francisco (Other)
720
1
2
59.1
12.2

Study Details

Study Description

Brief Summary

The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone.
N/A

Detailed Description

Studies have reported a rising incidence of anterior cruciate ligament (ACL) injuries in children and adolescents. Beck et al reported a 2.3% annual increase between 1994 and 2013. In New York State, the rate of pediatric ACL reconstruction climbed from 17.6/100,000 in 1990 to 50.9/100,000 by 2009. Other reports echo these findings. After ACL reconstruction, children are known to be at a higher risk for complications than adults. For example, while the rate of postoperative graft failure in adults was 3% to 4% in large national registries, as many as 12% to 19% of pediatric patients may sustain graft rupture. This can have substantial medical, financial, and psychosocial implications on the patient and family. Additionally, the results of revision ACL reconstruction are, on average, worse than after index surgery. Exploration of treatments that may lower the rate of re-injury is paramount in this population that is at highest risk.

In the adult population, a growing number of studies have suggested that concomitant reconstruction of the anterolateral ligament (ALL) with the ACL may help lower this risk. The ALL was likely first characterized in 1879 by the French surgeon Segond, who commented on the presence of a "pearly, resistant, fibrous band" in the lateral aspect of the knee. However, only in 2012 was the structure given the name "anterolateral ligament" after it was consistently identified in cadaveric specimens. Some studies suggest that the ALL is damaged during anterior cruciate ligament (ACL) injury, implying that it may supplement the ACL in providing rotational and translational stability. Biomechanical studies have confirmed that it likely plays a role in rotational stability.

A number of ALL reconstruction techniques have been developed with the hope of lowering the rate of re-injury after ACL reconstruction. Early literature in the adult population suggests that this may indeed be the case. Early case series suggested that concomitant ALL reconstruction resulted in high rates of return to sport and a low ACL graft failure rate (2.6%). Comparative retrospective studies in adults suggest better patient reported outcome scores, meniscal repair healing, and rates of return to sports when the ALL is reconstructed with the ACL compared to isolated ACL reconstruction. Finally, a prospective cohort study of adults reported that hamstring autograft ACL reconstruction with concomitant ALL reconstruction resulted in 3.1 times lower odds of graft failure than isolated hamstring ACL reconstruction and 2.5 times lower odds of failure than isolated patellar tendon ACL reconstruction.

The hypotheses to be tested in this study have never been evaluated in the pediatric population. Furthermore, the proposed investigation is a randomized controlled trial, which will allow it to provide novel results with high-level evidence. The results of such a study have the potential to change practice in a meaningful, tangible way and affect the outcomes of thousands of children annually. In addition to the medical and functional impact, there could also be important financial and psychosocial implications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
720 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will result in a lower rate of graft failure than ACL reconstruction alone.The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will result in a lower rate of graft failure than ACL reconstruction alone.
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Pediatric ALL Evaluation and Trial: A Randomized, Controlled Trial
Actual Study Start Date :
Apr 28, 2021
Anticipated Primary Completion Date :
Apr 1, 2026
Anticipated Study Completion Date :
Apr 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Concomitant ACL and ALL reconstruction

The participant will undergo both the ACL and ALL reconstruction surgery.

Procedure: Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone.
By randomizing patients into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone, following statistical analysis, we hope to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.

Experimental: ACL reconstruction alone

The participant will undergo only ACL reconstruction surgery.

Procedure: Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone.
By randomizing patients into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone, following statistical analysis, we hope to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.

Outcome Measures

Primary Outcome Measures

  1. Graft failure [Complete when all 780 participants have been recruited, received an intervention and have been followed for data collection for up to 5 years.]

    To determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure (confirmed graft re-tear or asymmetric, increased pivot shift) than ACL reconstruction alone.

Secondary Outcome Measures

  1. Complications of ALL reconstruction [Complete when all 780 participants have been recruited, received an intervention and have been followed for data collection for up to 5 years.]

    To determine the rate and severity of complications related specifically to ALL reconstruction in children.

  2. Patient reported outcome measures [Complete when all 780 participants have been recruited, received an intervention and have been followed for data collection for up to 5 years.]

    To collect and compare patient reported outcome (PRO) scores (as measured by the Pedi-IKDC, Lysholm, HSS Pedi-FABS, and PROMIS surveys) in children undergoing ACL reconstruction alone, and children undergoing combined ACL and ALL reconstruction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18 and under

  • Surgery within 6 months of injury

  • Undergoing primary ACL reconstruction without previous injury or surgery

  • Autograft ACL reconstruction

  • Closing or closed physes

Exclusion Criteria:
  • Over 18 years old

  • Previous ipsilateral knee injury or surgery

  • Neuromuscular or developmental disorders affecting knee anatomy, cognition, or neuromuscular control

  • Other concomitant ligament reconstruction aside from the ALL (i.e., MCL, PCL, PLC)

  • Revision ACL reconstruction

  • Allograft ACL reconstruction

  • IT band (modified MacIntosh) ACL reconstruction

  • A cartilage lesion requiring anything more than debridement

  • Open physes requiring both femoral and tibial physeal-sparing technique

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lurie Children's Hospital Chicago Illinois United States 60611

Sponsors and Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago
  • Children's Hospital of Philadelphia
  • Texas Children's
  • UCSF Benioff Children's Hospital - San Francisco

Investigators

  • Principal Investigator: Neeraj Patel, MD, Lurie Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Neeraj Patel, MD, MD, Orthopedic Surgery & Sports Medicine, Surgery, Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT04825587
Other Study ID Numbers:
  • 2020-3610
First Posted:
Apr 1, 2021
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2021